Canopy

Company Overview

Snapshot

Founded in April 2018 by Lavi Kwiatkowsky, Canopy operates with 11–50 employees. The company has raised $13 million across 3 funding rounds from 6 investors, with GSR Ventures as a lead investor. In March 2022, Canopy secured $13 million in funding to expand its Intelligent Care Platform for oncology, aiming to make it available to cancer treatment centers across the U.S. and recruit additional employees for its R&D center in Israel.

Business overview

Canopy is developing an Intelligent Care Platform designed to integrate with electronic medical records, providing interoperable software solutions for oncology care. Its core technology includes ePRO and device-based remote patient monitoring, decision-support tools, quality program management, oral adherence solutions, provider workflow, collaboration tools, and automated reimbursement capture. The platform serves practices of all sizes within the healthcare and life sciences sectors, specifically targeting oncology providers to enhance patient experience and outcomes while optimizing organizational success in the evolving oncology landscape.

Strategic signal

In March 2025, Canopy signed a significant deal with one of the world's largest oncology clinic networks. This partnership signals strong market validation for Canopy's Intelligent Care Platform and indicates a substantial expansion of its reach within the global oncology treatment sector, suggesting increased adoption and potential for revenue growth.

Company Intelligence Q&A

What was a significant recent partnership for Canopy?

In September 2023, Canopy partnered with New York Cancer & Blood Specialists (NYCBS) to optimize cancer care initiatives. NYCBS, which manages value-based care for over 10,000 patients, is utilizing Canopy's platform to enhance program effectiveness, identify and prioritize patients, resolve issues remotely, and integrate electronic patient-reported outcomes (ePRO) for remote symptom monitoring.

What was Canopy's most recent funding round?

In March 2022, Canopy raised $13 million in a funding round led by GSR Ventures, with participation from. This capital was earmarked for expanding its Intelligent Care Platform to cancer treatment centers across the U.S. and for recruiting R&D personnel in Israel.

What is the primary goal of Canopy's Intelligent Care Platform?

Canopy's Intelligent Care Platform aims to enable oncology providers to deliver higher quality care and improve patient outcomes at a lower cost by providing a layer of interoperable software solutions over electronic medical records. This includes tools for remote patient monitoring, decision support, and workflow optimization.

When was Canopy founded and by whom?

Canopy was founded in April 2018 by Lavi Kwiatkowsky.

What is the strategic significance of Canopy's deal with a major oncology clinic network?

In March 2025, Canopy secured a significant deal with a major global oncology clinic network. This collaboration is strategically important as it demonstrates substantial market penetration and validation for Canopy's platform, positioning the company for broader adoption and impact within the oncology care ecosystem.